CVE-2024-45097: IBM Aspera Faspex bypass security
Vulnerability summary
CVE-2024-45097 is a high (CVSS 7.1) vulnerability in ibm aspera_faspex. EPSS estimates a 0.31% chance of exploitation in the next 30 days, higher than 23.8% of scored vulnerabilities.
Not severe (CVSS 5.9, network access); no exploitation reported by the 5 checked sources
Source freshness unavailable
How is this decided?Timeline
- 05-09-2024PublishedVulnerability first disclosed.
- 05-09-2024Last modifiedVulnerability information updated.
Description
IBM Aspera Faspex 5.0.0 through 5.0.9 could allow a user to bypass intended access restrictions and conduct resource modification.
CVSS metrics
2 scores · 2 sources · 1 version- CVE.orgCNA5.9MediumCVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:H/A:NDiffers
EPSS trend
Probability
0.31%
Chance of exploitation in the next 30 days
Percentile
24%
Versus all other CVEs
30-day change
No change 0.00 pp
From 0.31% on 11-10-2026
Known exploited
Compare KEV catalogsNot in the CISA KEV catalog.
Not in the ENISA CNW catalog.
Not in the CIRCL catalog.
Public exploits
0 foundNo public exploits indexed.
Weaknesses
CWE · root cause- CWE-650Trusting HTTP Permission Methods on the Server SideThe server contains a protection mechanism that assumes that any URI that is accessed using HTTP GET will not cause a state change to the associated resource.
- CWE-436Interpretation ConflictProduct A handles inputs or steps differently than Product B, which causes A to perform incorrect actions based on its perception of B's state.
Affected systems
Known conditions: network-reachable, low-privilege account, no user interaction (CVSS vector). Other conditions: not stated in public data.
Ibm1 product
- aspera_faspex≥ 5.0.0, ≤ 5.0.9 | ≥ 5.0.0, < 5.0.10
1 vendor · 1 product
References
1 links- www.ibm.com/support/pages/node/7167255Vendor Advisory